Frederick Pierce
Amministratore Delegato presso INNOVATION1 BIOTECH INC.
Posizioni attive di Frederick Pierce
Società | Posizione | Inizio | Fine |
---|---|---|---|
METASTAT, INC. | Contatto Relazioni con gli Investitori | 01/03/2015 | - |
Public Communications Contact | 01/03/2015 | - | |
INNOVATION1 BIOTECH INC. | Presidente | 06/12/2022 | - |
Amministratore Delegato | 06/12/2022 | - | |
Presidente | 06/12/2022 | - | |
Direttore/Membro del Consiglio | 09/09/2022 | 06/12/2022 | |
Decoy Therapeutics, Inc. | Amministratore Delegato | - | - |
Fondatore | - | - | |
Canadian Entrepreneurs In New England
Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Canadian Entrepreneurs In New England operates a membership organization that supports Canadian technology and life sciences entrepreneurs. The private company is based in Boston. The American company was founded by Chris Legg. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Frederick Pierce
Precedenti posizioni note di Frederick Pierce
Società | Posizione | Inizio | Fine |
---|---|---|---|
Leadership Counsel for Justice & Accountability
Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Leadership Counsel for Justice & Accountability is an organization that aims to address the inequality faced by low-income rural regions in the United States. The organization fundamentally shifts the dynamics that have created this inequality, with a focus on the Sa region. | Presidente | 01/01/2017 | 01/01/2020 |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Presidente | 01/07/1998 | 01/06/2006 |
Microbial Machines, Inc. | Amministratore Delegato | - | - |
SEMBIOSYS GENETICS I | Corporate Officer/Principal | - | - |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Amministratore Delegato | - | - |
Presidente | - | - | |
░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Frederick Pierce
Hampshire College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Canada | 2 |
Posizioni
Chief Executive Officer | 4 |
Chairman | 3 |
President | 2 |
Settori
Commercial Services | 4 |
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
METASTAT, INC. | Producer Manufacturing |
INNOVATION1 BIOTECH INC. | Retail Trade |
Aziende private | 9 |
---|---|
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
SemBioSys Genetics, Inc.
SemBioSys Genetics, Inc. BiotechnologyHealth Technology SemBioSys Genetics, Inc. operates as a plant-based technology development company, which engages in the manufacturing technology platforms to develop, manufacture and commercialize healthy living, animal health and pharmaceutical products. It offers proteins, functional food and nutritional products. The company was founded by Maurice Moloney on April 25, 1994 and is headquartered in Calgary, Canada. | Health Technology |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
FEP Capital Advisors LLC | |
Canadian Entrepreneurs In New England
Canadian Entrepreneurs In New England Miscellaneous Commercial ServicesCommercial Services Canadian Entrepreneurs In New England operates a membership organization that supports Canadian technology and life sciences entrepreneurs. The private company is based in Boston. The American company was founded by Chris Legg. | Commercial Services |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | Health Technology |
Leadership Counsel for Justice & Accountability
Leadership Counsel for Justice & Accountability Miscellaneous Commercial ServicesCommercial Services Leadership Counsel for Justice & Accountability is an organization that aims to address the inequality faced by low-income rural regions in the United States. The organization fundamentally shifts the dynamics that have created this inequality, with a focus on the Sa region. | Commercial Services |
Decoy Therapeutics, Inc. | |
Microbial Machines, Inc. |
- Borsa valori
- Insiders
- Frederick Pierce
- Esperienza